Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.

about

Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.

Item

http://www.wikidata.org/entity/Q39122689

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel developments in foam scl ...... management of varicose veins.

@en

Novel developments in foam sclerotherapy: Focus on Varithena®

@nl

type

Item

label

Novel developments in foam scl ...... management of varicose veins.

@en

Novel developments in foam sclerotherapy: Focus on Varithena®

@nl

prefLabel

Novel developments in foam scl ...... management of varicose veins.

@en

Novel developments in foam sclerotherapy: Focus on Varithena®

@nl

P1476

Novel developments in foam scl ...... management of varicose veins.

@en

P2093

Phoebe Star

http://www.w3.org/2001/XMLSchema#string

P2860

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Three cases of stroke following peripheral venous interventions.

European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.

The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.

The incidence and outcome of endothermal heat-induced thrombosis after endovenous laser ablation.

Properties of polidocanol foam in view of its use in sclerotherapy.

Morphological changes in vascular and circulating blood cells following exposure to detergent sclerosants.

Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).

Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument

The VVSymQ® instrument: Use of a new patient-reported outcome measure for assessment of varicose vein symptoms.

P304

150-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0268355516687864

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David E. Connor

K Parsi

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28166694

http://www.w3.org/2001/XMLSchema#string